ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.

Eating disorders in athletes are common-yet sometimes missed. The outcomes of this can be dire. Here's what to know and what ...

He attempts to cross Norway in a perfectly straight line without following roads or established trails. The route forces him ...

President Donald Trump is crossing “a dangerous line” by attacking the Supreme Court for overturning his controversial tariffs, according to America’s most distinguished organization of lawyers. “The ...

Prosecutors and defense attorneys clashed over a witness' possible testimony in the bribery trial of two former FirstEnergy ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

Numerous developments in the criminal trial of two former FirstEnergy executives happened last week within and outside of witness testimony.

Innovation at driver level yields major advance for simple AC power controls STMicroelectronics (NYSE:STM)GENEVA, ...

An Horry County judge on Friday rejected North Myrtle Beach businessman Weldon Boyd’s request for immunity after hearing four ...

Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine ...